614 news items
Page 11 of 31
0divc94bs8r b2ygzes3
AZN
19 May 24
Attenuated Vaccines
The concomitant use of TEZSPIRE and live attenuated vaccines has not been evaluated
tgscib4ffzf1ryldehztrexfifmh3q4w6cvrix0d
AMGN
19 May 24
.
Live Attenuated Vaccines
6q2n qwzxstcc
17 May 24
lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. The prescribing information for tarlatamab-dlle includes a Boxed
6r1v7c b67ublgg05
IMRX
MGNX
MRUS
17 May 24
moving forward with partners BioNTech for a jointly-developed pancreatic cancer vaccine
5ix8bp3i7il5c3ffmkh0ck41uy7u
BNTX
17 May 24
and commercialization of a leading COVID-19 vaccine, BioNTech has shown that it can deliver against targeted objectives successfully. Today, BioNTech's
s5hjfawv8r25 xtnx
IBRX
17 May 24
and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we
eak2h 0r1mnsytcxdeu63y3qzfp6vnmto37q9x263w85kbgg45exytoh
ABBV
17 May 24
received or are scheduled to receive an immunization (vaccine). Medicines that interact with the immune system may increase your risk of getting
hgz1cyvd36bmnz3o1oel4n775e8diqtr
17 May 24
is recommended for all patients, particularly those with risk factors for skin cancer
3tpsjgplzeqd52v31wk1x8bmlu7s7zupfnc0
PFE
16 May 24
and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance
uu7x4hy 5who2b0gaaypmsyr4min9qgu
MRK
16 May 24
, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has
uzq ek8k8m
BVAXF
16 May 24
immune-educating technology platform and its HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious
q0sa4wqs4s01m7klsuu3lta4 28
BVAXF
16 May 24
-educating technology platform and its HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease
lvav8a9a
AZN
16 May 24
benefit of sipavibart in an evolving variant landscape.
Immunocompromised people include those with blood cancer, organ transplant
l4hkn8g58z13su1t6 8rotd
BMY
16 May 24
a successfully treated non-melanoma skin cancer) and patients who develop a malignancy when on treatment with SOTYKTU
cnq96ngl3sg i8k5fib
CVM
16 May 24
(FDA) for its confirmatory Registration Study of Multikine* in the treatment of head and neck cancer based on very strong safety and efficacy
kdsfj9v2fs2s2laqf8opz
AZN
BAYRY
GSK
16 May 24
(NASDAQ:MRNA), Merck developed an experimental mRNA cancer vaccine to treat melanoma. Merck and Moderna ended 2023
3ubk49ffiy9gloplmt58fyb8q3hay0f08gzpfj5y
OCEA
16 May 24
– and therefore has the potential of significantly greater efficacy compared with vaccines and therapeutics targeting other stages. Ocean is working
hwzgy30c7 rwjfmw9k2b8ygx31mpk96cxekatm2ebtpb
SNGX
16 May 24
patients to receive 8 weeks of HyBryte™ treatment of their cancerous lesions, with an assessment of treatment response conducted at week 10
sri62m6z0eudx3h5a30z3p2j0xt3j6jdyjz6sxu4
ARVN
PFE
16 May 24
at the San Antonio Breast Cancer Symposium (SABCS) in December 2023, and show that vepdegestrant plus palbociclib continue to demonstrate encouraging
klv7azr887kx00xlujdkdt6 qxdc62uovnf6h7t0
BMY
15 May 24
in the National Comprehensive Cancer Network (NCCN®) Clinical Practice Guidelines in Oncology (NCCN